Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterology 2021 September;67(3) > Minerva Gastroenterology 2021 September;67(3):215-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL  IMPACT OF DIRECT ANTIVIRAL AGENTS (DAAS) ON EXTRAHEPATIC DISEASES IN PATIENTS WITH CHRONIC HEPATITIS C Free accessfree

Minerva Gastroenterology 2021 September;67(3):215-7

DOI: 10.23736/S2724-5985.21.02924-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Long-term benefits of viral clearance on extrahepatic manifestations of hepatitis C virus infection: the light at the end of the tunnel?

Giorgio M. SARACCO ✉

Unit of Gastrohepatology, Department of Medical Sciences, University of Turin, Turin, Italy


HTML PDF


top of page

 

Copyright © 2023 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions